Genetron
(NASDAQ) GTH
Genetron Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$650.71M
Net Income (TTM)
$801.96M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GTH News
GTH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genetron
Industry
Biotechnology
Sector
Health CareEmployees
993
CEO
Si Zhen Wang, MBA
Website
ir.genetronhealth.comHeadquarters
Beijing, 102206, CN
GTH Financials
Key Financial Metrics (TTM)
Gross Margin
43%
Operating Margin
-97%
Net Income Margin
-1%
Return on Equity
-1%
Return on Capital
-1%
Return on Assets
-91%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$281.43M
Operating Income
$631.62M
EBITDA
$651.24M
Operating Cash Flow
$460.20M
Capital Expenditure
$82.14M
Free Cash Flow
$542.34M
Cash & ST Invst.
$333.69M
Total Debt
$158.57M
Genetron Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$201.32M
+37.1%
Gross Profit
$81.93M
-2.1%
Gross Margin
40.70%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
993
N/A
Net Income
$199.41M
-22.6%
EBITDA
$163.29M
-7.6%
Quarterly Fundamentals
Net Cash
$338.86M
-52.7%
Accounts Receivable
$257.93M
-33.6%
Inventory
$82.73M
+132.4%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-90.62%
N/A
Return on Invested Capital
-1.08%
N/A
Free Cash Flow
$520.55M
-585.4%
Operating Cash Flow
$452.61M
-567.8%